BioCentury China Healthcare Summit
The 5th BioCentury China Healthcare Summit will gather top thinkers from industry, academia and finance to identify who will lead China's biopharma innovation ecosystem, how innovation will be funded, and the business strategies required to transform both domestic and multinational biopharmas and medtech companies as China advances its innovation agenda. Attendance is limited at this strategic, VIP-only event to ensure intimate dialogue and networking among peers.
The BioCentury China Healthcare Summit will include discussion of an exclusive conference report from our Insights Partner, McKinsey & Company, on transforming biopharma and medtech business models as China's healthcare system evolves. The Summit will also host the annual BayHelix Awards to celebrate R&D and commercial achievements in China, and a special half-day Science & Innovation Showcase.
The agenda has been developed by an organizing committee that includes China industry KOLs and BioCentury's editorial team. Simultaneous translation is provided in all sessions.